Qsymia as an Adjunct to Surgical Therapy in the Superobese
Status:
Completed
Trial end date:
2018-06-27
Target enrollment:
Participant gender:
Summary
This study tests the efficacy of the medication, Qsymia, as an adjunct therapy in superobese
individuals planning to undergo weight loss surgery. Individuals taking the medication before
and after surgery will be compared to historical controls who had surgery without taking the
medication.